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Abstract
BACKGROUND/AIMS—To examine the relationship between change in optic nerve head 
(ONH) morphology and retinal blood flow in patients with open-angle glaucoma (OAG) of 
African (AD) and European descent (ED) over three years.
METHODS—112 patients with OAG (29 AD; 83 ED) underwent assessment of ONH 
morphology using Heidelberg retinal tomography (HRT-III) and retinal blood flow using confocal 
scanning laser Doppler. Repeated measures analysis of covariance was used to compare baseline 
and 3-year measurements and Pearson correlations were calculated to evaluate the relationships.
RESULTS—In OAG patients of AD, change in superior mean retinal blood flow was strongly, 
negatively correlated with change in cup/disc (C/D) area ratio (r=−0.78, p=0.020) and cup area (r=
−0.75, p=0.0283) and strongly, positively correlated with change in rim area (r=0.74, p=0.0328) 
over three years. In OAG patients of AD, change in inferior mean retinal blood flow was strongly, 
negatively correlated with changes in C/D area ratio (r=−0.88, p=0.0156) and linear C/D ratio (r=
−0.86, p=0.0265) over three years. In OAG patients of ED, these correlations were weak and did 
not reach statistical significance.
DISCUSSION—OAG patients of AD may have a stronger vascular component to their glaucoma 
pathophysiology than patients of ED.
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INTRODUCTION
Glaucoma is a leading cause of blindness worldwide. Glaucoma disproportionately affects 
persons of African descent (AD), affecting six times more persons of AD than those of 
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European descent (ED).[1,2] Persons of AD also have a predilection for earlier development 
of open-angle glaucoma (OAG), increased disease severity and experience glaucoma 
progression more quickly, resulting in greater loss of visual function.[3–8] Despite the 
disparity in glaucoma progression between persons of AD and ED, the contributing 
mechanisms accounting for such differences in disease disparity have yet to be elucidated.
Although OAG is a leading cause of impaired vision worldwide, intraocular pressure (IOP) 
remains the only treatable risk factor for the disease. However, a high percentage of 
individuals with elevated IOP do not develop glaucoma while glaucoma progression often 
occurs despite meeting target IOP.[9] The involvement of other contributing factors 
including insufficient ocular blood flow and metabolism have been previously established in 
many patients. These vascular impairments include deficiencies of the retinal, choroidal and 
retrobulbar circulations.[10,11] Numerous clinical studies have also demonstrated that 
systemic and local vascular complications, including arterial hypertension, optic disc 
hemorrhage and aging of vasculature are associated with OAG.[10,12]
Importantly, the involvement of ocular blood flow in glaucoma may be especially present in 
persons of AD as they are known to higher rates of systemic vasculature abnormalities. The 
American Heart Association states that the death rate per 100,000 persons for cardiovascular 
disease was 28.7 for white males, 39.0 for black males, 20.1 for white females and 27.7 for 
black males.[13] Persons of AD have been noted to have a 2.5-fold increase in stroke risk 
compared to persons of ED.[14,15] Furthermore, in the African Descent and Glaucoma 
Evaluation Study (ADAGES), persons of AD were found to have higher blood pressure and 
a higher rate of diabetes mellitus.[16]
Due to the presence of increased systemic vasculature pathology and the increased severity 
and frequency of glaucoma in persons of AD, investigating changes in the retinal circulation 
in relation to changes in optic nerve head (ONH) structure over time may reveal a previously 
unreported contributing mechanism to AD OAG pathophysiology. To the best of our 
knowledge, we herein report the first prospective study that investigates how changing 
retinal capillary blood flow may contribute to glaucomatous changes in ONH morphology in 
patients of AD versus ED.
MATERIALS AND METHODS
112 patients with OAG (29 AD; 83 ED) were prospectively examined within the 
Department of Ophthalmology at the Indiana University School of Medicine over a period 
of 36 months. All patients signed an informed consent after explanation in accordance with 
the Declaration of Helsinki, and the study protocol was approved by the Institutional Review 
Board.
The diagnosis of OAG was defined as optic disc cupping and repeatable reliable visual 
fields (SITA standard 24–2 perimetry) with glaucomatous damage prior to study entry, and 
confirmed by two separate visual field exams one week apart within the study (baseline 
exams). Diagnosis of OAG was confirmed in both criteria (prior to entry and at study entry) 
by a fellowship-trained glaucoma specialist (in the study eye): specifically, visual field 
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damage was consistent with glaucomatous damage (nasal step, arcuate field defect, or 
paracentral depression in clusters of test sites), and visual field loss in the upper hemifield 
that is different compared with the lower hemifield, i.e., across the horizontal midline (in 
early/moderate cases). The two cohorts were recruited as first comers who had qualified 
glaucoma (defined above) and were free from cardiovascular, renal, or pulmonary disease. 
Use of preventative blood pressure and cholesterol lowering medications were allowed in 
participants. IOP was measured with Goldmann applanation tonometry. Patient data were 
categorized into groups AD or ED based on self-reported race. Reporting of race other than 
AD or ED (i.e. Asian or Hispanic ethnicity) were excluded from this analysis.
Topographic analysis of the ONH was performed using the Heidelberg Retinal Tomograph 
version III (HRT3) (Heidelberg Engineering, Dossenheim, Germany), which provides 
topographic measurements of the optic nerve head. The dioptric ring of the HRT was 
adjusted to the spherical equivalent of any refractive error and cylindrical correction was 
added if needed. Topographic images were performed with an un-dilated pupil in most 
cases. If dilation was required it was achieved using tropicamide 0.5%. The drawing of the 
optic disc margins in all patients were manually traced by the same experienced 
ophthalmologist at baseline. The margin was drawn at the inner edge of the Elschnig’s ring 
with at least 4–6 contour line points. The parameters investigated in this study were cup 
area, rim area, cup/disc (C/D) area ratio and linear C/D ratio. Linear cup/disc area ratio is 
defined by HRT3 as the average of the cup/disc diameter ratios (square root of cup/disc area 
ratio).
Confocal scanning laser Doppler flowmetry (Heidelberg Retinal Flowmeter (HRF), 
Heidelberg Engineering, Heidelberg, Germany) was used to measure perfusion within 
peripapillary retinal capillary beds. The HRF utilizes an infrared laser to scan the retina. The 
frequency and amplitude of Doppler shifts in the reflected light allow for determination of 
blood velocity and blood volume, respectively. This information is used to compute total 
blood flow and to create a physical map of flow values contained in the retina. Peripapillary 
retinal capillaries were sampled individually using pixel by pixel analysis in a 40×40 pixel 
area (~1,600 individual pixels per scan) for both supero-temporal and infero-temporal areas 
adjacent to the optic nerve. During the image acquisition, the refractive error of each eye 
was adjusted in the dioptric ring to produce the best image quality. Poorly focused pixels 
from the rim, large blood vessels, saccades and areas with improper brightness (any DC 
value <80 or >200) were excluded.
AD and ED patient cohorts were compared for differences in baseline measurements using 
analysis of covariance (ANCOVA). Repeated measures analysis of covariance 
(rmANCOVA) was used to evaluate changes from baseline to 3-year follow up. Pearson 
correlations were calculated to evaluate the associations between the changes in 
measurements between baseline and 3 years for each group. Correlations were adjusted for 
years of glaucoma, use of glaucoma medications, use of hypertension medication, age 65 or 
older, BMI category, diabetes, and sex. Correlations were compared between groups using 
Fisher’s z-tests. P values < 0.05 were considered statistically significant.
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RESULTS
Table 1 demonstrates the baseline characteristics of all 112 patients with OAG (29 AD; 83 
ED) examined in this study. BMI, systolic BP, heart rate did not differ between AD and ED 
at baseline. Hypertension medications were similar in both groups (41% AD, 45% ED, 
p=0.77). Cholesterol medications were more prevalent among ED than AD (19% AD, 40% 
ED, p=0.03). Prostaglandin medication was not different in AD and ED (52% AD, 64% ED, 
p=0.25), however other glaucoma mediation were higher in AD than ED (62% vs. 34%, 
P=0.01). At baseline, there were no significant differences (P>0.05) between persons of AD 
compared to ED with respect to IOP, OPP, visual field mean deviation and pattern standard 
deviation, and ONH parameters. Changes in the measurements between baseline and 3-year 
follow-up are shown in Table 2. Over the 3 year study period IOP decreased in ED 
(p=0.001) while visual field PSD (p=0.004) and superior mean retinal flow (p=0.009) 
increased significantly in the AD group; however there were no statistically significant 
differences over time between groups. Additionally, no participants in either group were 
subsequently diagnosed with systemic cardiovascular disease over the 3-year study and there 
were also not any significant changes in ocular or systemic medication use from baseline.
Table 3 demonstrates the Pearson correlation values and their significance for ONH 
structure parameters in relation to mean retinal capillary blood flow. In OAG patients of 
AD, change in superior (area) mean retinal blood flow was strongly, negatively correlated 
with changes in C/D area ratio and cup area, and strongly, positively correlated with changes 
in rim area over three years with statistical significance. In OAG patients of AD, change in 
inferior (area) mean retinal blood flow was also strongly, negatively correlated with changes 
in C/D area ratio and linear C/D ratio over three years with statistical significance. In OAG 
patients of ED, these correlations were weak and did not reach statistical significance 
(p>0.05). The difference in strength of correlations between AD and ED groups was 
statistically significant for each relationship (p<0.05).
DISCUSSION
Although persons of AD have been found to have higher rates of glaucoma prevalence and 
progression compared to persons of ED, the contributory mechanisms explaining these 
differences have not yet been determined.[1–8] Risk factors independent of IOP, including 
vascular impairment, may help to explain this disparity as both impaired vascular function 
has been associated with glaucoma incidence, prevalence and progression [10,11,17–19] and 
persons of AD are known to have elevated systemic vascular disease. Persons of AD are 
known to have increased rates of systemic vascular diseases such as hypertension and 
cardiovascular disease compared to persons of ED.[13–16] This is an important aspect of 
glaucoma risk to evaluate in AD populations as studies have found decreased systemic and 
ocular blood flow to be correlated with glaucomatous structural damage in the retina and 
ONH.[10,11,18,19] Results from the Ocular Hypertension Treatment Study (OHTS) suggest 
that increased rates of cardiovascular disease in AD persons may be linked to increased rates 
of glaucoma.[20] Our study investigated OAG patients of AD and ED with respect to retinal 
capillary blood flow and it’s impact on glaucomatous ONH structural progression over time 
in patients currently free from these diseases.
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In this cohort of patients, there was no difference at baseline between the two groups with 
respect to IOP, visual field mean deviation and pattern standard deviation, and HRT3 C/D 
area ratio, cup area, rim area and linear C/D ratio. This helps establish that the differences 
between study groups was not likely related to differing disease severity or IOP-related 
influence at baseline. Examining change over three years, persons of AD were found to have 
a strong, significant correlation between change in retinal capillary blood flow in both the 
superior and inferior temporal retina areas and change in ONH parameters including: C/D 
area ratio, cup area, rim area and linear C/D area ratio. These same associations were weak 
and not statistically significant in patients of ED, with the differences between the two 
groups reaching statistical significance in each parameter. It is interesting that the AD group 
had slightly increasing retinal flow over time as a group. This may represent a compensatory 
mechanism to protect retinal ganglion cells under duress, or may simply be a chance finding 
as the changes over time where not statistically different in comparison to the ED group. We 
feel the most important findings are the stark statistical differences in the relationships of 
retinal blood flow to structural damage of the ONH between Ad and ED patients. These data 
indicate the strong probability that alterations to retinal capillary blood flow may be more 
apparent in OAG patient of AD compared to their ED counterparts and may help explain 
non-IOP related relative risk.
A previous study by Resch et al. found that reduced retinal blood flow was strongly 
correlated with ONH damage and visual field loss in OAG patients (non-race specific).[18] 
In a similar study, Logan et al. found OAG patients with optic discs that had abnormal 
segments had retinal capillary blood flow values that were lower than those with a 
corresponding normal segment.[19] These studies suggest that retinal blood flow is related 
to glaucomatous ONH damage in some patients and taken in conjunction with our data, 
suggests the possibility that persons of AD might have a stronger retinal vascular component 
to their glaucomatous progression than persons of ED.
Recently our group, Siesky et al [21], conducted a retrospective study of retrobulbar blood 
flow parameters in AD and ED OAG patients. This study found a uniform reduction in 
retrobulbar blood flow in AD patients compared to ED patients within all retrobulbar blood 
vessels including the ophthalmic artery, central retinal artery, nasal short posterior ciliary 
artery and temporal short posterior ciliary artery. These results are in agreement with our 
data, suggesting that patients of AD may be at increased risk for vascular deficits in all 
ocular vascular beds and that these differences may subsequently put patients of AD at a 
greater risk for OAG pathology at similar IOP levels. While not conclusive, this analysis 
suggests a possible vascular contributory mechanism of structural glaucoma progression 
over time in patients of AD..
Our study has several limitations to acknowledge. Race was self-reported, however, self-
described race has previously demonstrated a high correlation with more sophisticated 
measures of racial classification.[8] Our study also only assessed retinal capillary blood flow 
measurements and did not take into account the effect of other vessels involved in the supply 
of ocular tissues, although our previous retrospective investigation [21] suggests all ocular 
vascular beds may be susceptible. It also is important to note that use of preventative blood 
pressure and cholesterol lowering medications were allowed in participants, although blood 
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pressure treatments did not significantly differ between groups. Additionally, it is possible 
that visual field changes over time may differ from the ONH structural changes that we 
observed and would be a pertinent future direction of this research.
To the best of our knowledge, this study is the first of its kind to prospectively measure 
glaucomatous ONH progression in relation to changes in retinal capillary blood flow in AD 
versus ED OAG patients. As studies have previously found decreased retinal capillary blood 
flow to be associated with glaucomatous structural damage our findings further suggest that 
changes over time in the retinal circulation may be compromised in persons of AD and that 
this may contribute to glaucomatous ONH structural progression. This mechanism may help 
to explain, in part, the disparity in OAG disease between persons of AD and ED. More 
studies, including those that assess visual field progression, are needed to further elucidate 
causality in the disparity of OAG in AD and ED patients and are strongly encouraged.
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TABLE 1
Baseline measurements in persons of African Descent v. European Descent
African Descent
Mean (95% CI)
European Descent
Mean (95% CI)
p-value
Sex (n=) Male: 21 Male: 47 0.1340
Female: 8 Female: 36
Mean age (years) 66 66 0.9311
BMI 29.4 (28.2, 30.7) 29.0 (28.3, 29.8) 0.5822
Systolic BP 138.8 (129.8, 147.8) 134.4 (128.8, 140.0) 0.3733
Heart Rate 72.0 (67.0, 77.3) 71.2 (68.1, 74.4) 0.7757
IOP 16.98 (14.92, 19.04) 16.04 (14.76, 17.32) 0.4035
OPP 51.58 (46.75, 56.40) 50.15 (47.15, 53.14) 0.5885
VF MD −3.67 (−2.18, −5.38) −2.63 (−1.76, −3.57) 0.2122
VF PSD 3.57 (2.48, 4.99) 3.20 (2.54, 3.97) 0.5659
Superior Mean Retinal Flow 430 (383, 482) 399 (371, 428) 0.2336
Inferior Mean Retinal Flow 477 (414, 550) 393 (361, 429) 0.0135
HRT3 Cup Area 0.955 (0.714, 1.196) 0.946 (0.793, 1.099) 0.9469
HRT3 Rim Area 1.320 (1.136, 1.504) 1.202 (1.085, 1.319) 0.2444
HRT3 C/D Area Ratio 0.413 (0.328, 0.498) 0.420 (0.366, 0.474) 0.8888
HRT3 Linear C/D Ratio 0.630 (0.553, 0.707) 0.625 (0.576, 0.675) 0.9156
IOP=intraocular pressure, OPP=ocular perfusion pressure, VF=visual field, MD=mean deviation, PSD=pattern standard deviation, HRT3= 
Heidelberg Retinal Tomograph version III, C/D=cup/disk. Races were compared for differences in baseline measurements using analysis of 
covariance.
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TABLE 2
Change from Baseline to 3-year follow-up in persons of African Descent v. European Descent
African Descent
Mean (95% CI)
European Descent
Mean (95% CI)
p-value
BMI
Systolic BP −5.58 (−14.17, 3.02) −1.62 (−6.57, 3.33) 0.4294
Heart Rate 2.06 (−2.14, 6.02) 0.61 (−1.79, 2.94) 0.5486
IOP −1.33 (−3.11, 0.46) −1.70 (−2.71, −0.70) 0.7148
OPP 0.03 (−4.17, 4.22) 1.89 (−0.49, 4.27) 0.4429
VF MD 0.00 (0.78, −0.73) −0.30 (0.10, −0.68) 0.4456
VF PSD 0.72 (0.24, 1.14) 0.24 (−0.06, 0.51) 0.0836
Superior Mean Retinal Flow 74.70 (20.28, 121.79) 15.56 (−18.79, 47.05) 0.0734
Inferior Mean Retinal Flow −17.19 (−95.79, 50.22) 23.61 (−8.77, 53.28) 0.2546
HRT3 Cup Area 0.042 (−0.038, 0.121) 0.022 (−0.024, 0.068) 0.6674
HRT3 Rim Area −0.040 (−0.121, 0.041) −0.016 (−0.063, 0.031) 0.6008
HRT3 C/D Area Ratio 0.019 (−0.015, 0.054) 0.009 (−0.011, 0.029) 0.6036
HRT3 Linear C/D Ratio 0.007 (−0.023, 0.037) 0.007 (−0.010, 0.025) 0.9832
IOP=intraocular pressure, OPP=ocular perfusion pressure, VF=visual field, MD=mean deviation, PSD=pattern standard deviation, HRT3= 
Heidelberg Retinal Tomograph version III, C/D=cup/disk. Races were compared for differences in changes using analysis of covariance.
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